Skip to main content
Warning Date
    2008-05-26

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women

2008-05-26

Objective To assess the risk of venous thromboembolism in women using hormone replacement therapy by study design, characteristics of the therapy and venous thromboembolism, and clinical background.

Design Systematic review and meta-analysis.

Data sources Medline.

Studies reviewed Eight observational studies and nine randomised controlled trials.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-06-01

U.S. FDA Warns Consumers Against Using Mommy's Bliss Nipple Cream

2008-06-01

The us counterpart to the Saudi Food and Drug Authority ,U.S. Food and Drug Administration is warning consumers not to use or purchase Mommy's Bliss Nipple Cream, marketed by MOM Enterprises, Inc., because the product contains potentially harmful ingredients that may cause respiratory distress or vomiting and diarrhea in infants.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-07-07

CellCept and Myfortic Are Associated with the Development of Progressive Multifocal Leukoencephalopathy (PML)

2008-07-07

The U.S. food and drug administration (FDA), the equivalents of the Saudi food and drud authority (SFDA) announced that Novartis and Roche have issued a dear healthcare professional letters to inform them that use of Myfortic (mycophenolic acid) and CellCept (mycophenolate mofetil) , medicines used to prevent organ rejection are associated with the development of Progressive Multifocal Leukoencephalopathy (PML) .

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-07-29

Consumers Filling U.S. Prescriptions Abroad May Get the Wrong Active Ingredient Because of Confusing Drug Names

2008-07-29

The U.S Food and Drug Administration (FDA) is advising healthcare professionals and consumers that filling U.S. prescriptions abroad may give patients the wrong active ingredient for treating their health condition.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-08-03

New Safety Information regarding the antidiuretic drug desmopressin (DDAVP® Spray and DDAVP® Rhinyle Solution)

2008-08-03

Ferring Pharmaceuticals, in collaboration with Health Canada, the Canadian counterpart to the Saudi Food and Drug Authority (SFDA), inform health care professionals that all intranasal formulations of Desmopressin including Desmopressin Acetate Nasal(DDAVP) Spray & Desmopressin acetate Rhinyle Solution (DDAVP) are no longer indicated for the treatment of Primary Nocturnal Enuresis (PNE) due to an increased risk of hyponatremia with the intranasal formulations.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-08-07

Calcium, vitamin D supplements with or without alendronate and supragingival calculus formation in osteoporotic women

2008-08-07

Objectives : Long-term calcium intake is related to the formation of urinary stones. Structure and composition of kidney and gallstones are similar to dental calculus. Saliva is the source of calcium for supragingival dental calculus formation. The aim of this preliminary study was to evaluate the possible effects of long-term calcium and vitamin D supplementation with or without alendronate administration on salivary electrolyte concentrations and supragingival calculus formation in osteoporotic women.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-09-10

Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet

2008-09-10

Context Lead, mercury, and arsenic have been detected in a substantial proportion of Indian-manufactured traditional Ayurvedic medicines. Metals may be present due to the practice of rasa shastra (combining herbs with metals, minerals, and gems). Whether toxic metals are present in both US- and Indian-manufactured Ayurvedic medicines is unknown.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-09-16

Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia

2008-09-16

Background: Three warnings of serious adverse events associated with the use of atypical antipsychotic drugs among elderly patients with dementia were sent to health care professionals in Canada. We assessed the impact of these warnings on prescription rates of antipsychotic drugs in this patient population.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-11-04

Rosiglitazone no longer recommended

2008-11-04

GlaxoSmithKline (GSK) suffered a heavy blow at the hands of two leading diabetes societies. For the first time, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have issued guidelines that explicitly advise against the use of GSK's rosiglitazone for type-2 diabetes.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2008-11-26

US FDA issues alert on potential increased risk of serious skin reactions with phenytoin and fosphenytoin

2008-11-26

FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen (HLA) allele, HLA-B*1502. This allele occurs almost exclusively in patients with ancestry across broad areas of Asia, including Han Chinese, Filipinos, Malaysians, South Asian Indians, and Thais.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Subscribe to Drugs